After Trump win, bet on pharma: Sharekhan
We like Glenmark Pharma and Aurobindo because these two companies have extremely high approval rates10-11-2016
After Trump win, bet on pharma: Sharekhan
We like Glenmark Pharma and Aurobindo because these two companies have extremely high approval ratesOutcome of Board Meeting - Resignation of Company Secretary & Compliance Officer
Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on October 27, 2016 noted and approved the resignation of Mr. Sanjay Kumar Chowdhary, Company Secretary & Compliance Officer with effect from October 31, 2016.2 Diwali stock picks from Prabhudas Lilladher
"SBI and Glenmark are the two stocks we are recommending to our clients."Glenmark's Q2 profit grows at 3.5% despite 16% rise in revenue
Glenmark's net profit rose to Rs223.6 crore for the three months ended 30 September from Rs216.1 crore a year agoAnnounces Q2 results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated), Results Press Release & Management Discussion & Analysis for the Quarter ended September 30, 2016
Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2016The Unaudited Standalone results for the Quarter ended September 30, 2016 The Company has posted a net profit of Rs. 5558.28 million for the quarter ended September 30, 2016 as compared to Rs. 3721.74 million for the quarter ended September 30, 2015. Total Income has increased from Rs. 16276.29 million for the quarter ended September...Glenmark gets USFDA nod for anti-fungal ointment
Glenmark Pharmaceuticals today said it has received final approval from the US health regulator for antifungal ointment nystatin and triamcinolone acetonide. Glenmark Pharmaceuticals USA has...Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/g
Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of Press Release dated October 25, 2016 titled ''Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/g".Details of Earnings Call
Glenmark Pharmaceuticals Ltd has informed BSE about the details of Earnings Call slated for October 28, 2016, 8:30 a.m. - 9:30 a.m. (IST).Q2 results on Oct 27, 2016
Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on October 27, 2016, to consider and approve the Company's Unaudited Financial Statements for Second Quarter/Half Year ended September 30, 2016 (Q2).Further, as per the "Code of Conduct for Prevention of Insider Trading" of the Company, the trading window closed for Directors and other designated employees of the Company on September 29, 2016...Glenmark appoints Dr. Kurt Stoeckli as President and Chief Scientific Officer
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated October 13, 2016 titled "Glenmark appoints Dr. Kurt Stoeckli as President and Chief Scientific Officer".